Danimer Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-155.47	-179.76	-60.11	-8.85	-19.51	0.21
Depreciation & Amortization	29.06	20.09	10.63	5.12	4.07	3.54
Share-Based Compensation	56.04	56.96	55.27	3.65	5.27	0.87
Other Operating Activities	23.12	40.88	-68.76	-13.71	8.5	-4.29
Operating Cash Flow	-47.26	-61.84	-62.96	-13.8	-1.67	0.32
Capital Expenditures	-27.66	-164.43	-184.99	-38.26	-35.69	2.81
Acquisitions	0	-0.01	-151.18	0	0	0
Change in Investments	0	-18.04	0	0	-13.41	0
Investing Cash Flow	-27.66	-182.48	-336.17	-38.26	-49.09	2.81
Share Issuance / Repurchase	0.51	0.36	140.31	420.2	4.15	7.06
Debt Issued / Paid	83.67	21.61	202.66	2.47	49.35	-7.51
Other Financing Activities	-0.15	-0.21	-36.77	-	-	-
Financing Cash Flow	84.03	21.75	306.2	422.68	53.5	-0.45
Net Cash Flow	9.1	-222.57	-92.93	370.62	2.73	2.68
Free Cash Flow	-74.93	-226.27	-247.95	-52.06	-37.36	3.13
Free Cash Flow Margin	-160.50%	-425.17%	-422.05%	-109.98%	-115.50%	10.29%
Free Cash Flow Per Share	-0.73	-2.24	-2.66	-1.76	-1.48	1.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).